Donafenib: First Approval
This article summarizes the milestones in the development of donafenib leading to this first approval for use in unresectable hepatocellular carcinoma.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | China Health | Colorectal Cancer | Drugs & Pharmacology | Hepatocellular Carcinoma | Liver Cancer | Oral Cancer | Thyroid | Thyroid Cancer